|213.01||+7.05 / +3.42%|
As of 4:02pm ET
|213.02||+0.0051 / +0.00%|
The 5 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 269.00, with a high estimate of 300.00 and a low estimate of 263.00. The median estimate represents a +26.29% increase from the last price of 213.01.
The current consensus among 7 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.